2011
DOI: 10.1186/1750-1326-6-65
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold

Abstract: BackgroundMemory deficits in Alzheimer's disease (AD) manifest together with the loss of synapses caused by the disruption of the postsynaptic density (PSD), a network of scaffold proteins located in dendritic spines. However, the underlying molecular mechanisms remain elusive. Since it was shown that ProSAP2/Shank3 scaffold assembly within the PSD is Zn2+-dependent and that the amyloid beta protein (Aβ) is able to bind Zn2+, we hypothesize that sequestration of Zn2+ ions by Aβ contributes to ProSAP/Shank plat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
55
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 71 publications
(57 citation statements)
references
References 61 publications
2
55
0
Order By: Relevance
“…Western Blots were performed as previously described (Grabrucker et al, 2011). Protein concentration was determined by Bradford Assay; equal amounts of protein were separated using SDS-PAGE (polyacrylamide gel electrophoresis) and subsequently blotted on nitrocellulose membrane (GE Healthcare, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…Western Blots were performed as previously described (Grabrucker et al, 2011). Protein concentration was determined by Bradford Assay; equal amounts of protein were separated using SDS-PAGE (polyacrylamide gel electrophoresis) and subsequently blotted on nitrocellulose membrane (GE Healthcare, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…One highly replicated ASD-risk gene is SHANK3 (SH3 and multiple ankyrin repeat domains 3), which is a synaptic scaffolding protein that https://doi.org/10.1016/j.ijdevneu.2018.10.003 Received 10 August 2018; Received in revised form 21 October 2018; Accepted 26 October 2018 plays a crucial role in synaptic plasticity (Naisbitt et al, 1999;Grabrucker et al, 2011). Heterozygous deletions or point mutations of SHANK3 are thought to be the main cause of Phelan-McDermid Syndrome (PMS, also referred to as 22q13 Deletion Syndrome)a genetic disorder characterized by global developmental delay, delayed or absent speech, moderate to severe intellectual disability, dysmorphic features, neonatal hypotonia, seizures, and a strong co-morbidity with ASD (Bonaglia et al, 2001(Bonaglia et al, , 2006Phelan, 2008;Phelan and McDermid, 2011;Harony-Nicolas et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…8 The application of soluble amyloid β-protein (Aβ) decreases the ProSAP2/ Shank3 levels in the PSD, and this change in turn leads to reductions in Shank1 protein and synapse density in hippocampal neurons, whereas the level of the Shank2 protein is increased. 9,10 In AD, the process of synaptic damage could involve a beginning with dysregulation of synapse-related proteins such as PSD95 and Shank1. 11 AD patients with MCI demonstrated loss of postsynaptic markers such as PSD95 and Shank1.…”
Section: Introductionmentioning
confidence: 99%